Cite
Pradenas E, Trinité B, Urrea V, et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021;2(3):313-320.e4doi: 10.1016/j.medj.2021.01.005.
Pradenas, E., Trinité, B., Urrea, V., Marfil, S., Ávila-Nieto, C., Rodríguez de la Concepción, M. L., Tarrés-Freixas, F., Pérez-Yanes, S., Rovirosa, C., Ainsua-Enrich, E., Rodon, J., Vergara-Alert, J., Segalés, J., Guallar, V., Valencia, A., Izquierdo-Useros, N., Paredes, R., Mateu, L., Chamorro, A., Massanella, M., Carrillo, J., Clotet, B., & Blanco, J. (2021). Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (New York, N.Y.), 2(3), 313-320.e4. https://doi.org/10.1016/j.medj.2021.01.005
Pradenas, Edwards, et al. "Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes." Med (New York, N.Y.) vol. 2,3 (2021): 313-320.e4. doi: https://doi.org/10.1016/j.medj.2021.01.005
Pradenas E, Trinité B, Urrea V, Marfil S, Ávila-Nieto C, Rodríguez de la Concepción ML, Tarrés-Freixas F, Pérez-Yanes S, Rovirosa C, Ainsua-Enrich E, Rodon J, Vergara-Alert J, Segalés J, Guallar V, Valencia A, Izquierdo-Useros N, Paredes R, Mateu L, Chamorro A, Massanella M, Carrillo J, Clotet B, Blanco J. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021 Mar 12;2(3):313-320.e4. doi: 10.1016/j.medj.2021.01.005. Epub 2021 Jan 31. PMID: 33554155; PMCID: PMC7847406.
Copy
Download .nbib